Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets

Bone

Volumn 10, Issue 6, 1989, Pages 401-407

  Arnold, P ^a   Wermeille, M ^b   Chapuy, M C ^c   Biollaz, J ^d   Grandjean, E M ^b   Schelling, J L ^d   Meunier, P J ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c INSERM   (France)

^d NONE

Author keywords

Antacid; Bioavailability; coated tablets; Enteric; Food; Sodium fluoride

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM MAGNESIUM HYDROXIDE; FLUORIDE SODIUM;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED STUDY; ENTERIC COATED TABLET; FEMALE; FOOD; HUMAN; HUMAN EXPERIMENT; MALE; METHODOLOGY; NORMAL HUMAN; ORAL DRUG ADMINISTRATION;

ADULT; ALUMINUM HYDROXIDE; BIOLOGICAL AVAILABILITY; CALCIUM; DRUG COMBINATIONS; FEMALE; FLUORIDES; FOOD; HUMAN; INTESTINAL ABSORPTION; MAGNESIUM; MAGNESIUM HYDROXIDE; MALE; SODIUM FLUORIDE; TABLETS, ENTERIC-COATED; URINE;

EID: 0024942550     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(89)90070-7     Document Type: Article

References (36)

1. Use of sodium fluoride in the treatment of osteoporosis
2. Treatment of osteoporosis with fluoride, calcium, and vitamin D
3. Comparaison de la biodisponibilité du fluor à la suite de l'administration de fluorure de sodium seul ou en association avec du calcium
4. ®
5. Absorption of fluorides
6. Pharmacokinetics of fluoride in man after single and multiple oral doses
7. Influence of milk products on fluoride bioavailability in man
8. Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow
9. The State of Fluorine in Milk and its Absorption and Retention When Administered in Milk. Investigations with Radioactive Fluorine
10. Our experience in the treatment of osteoporosis with relatively low sodium fluoride doses
11. Three years' experience with sodium-fluoride therapy of osteoporosis
12. PHARM: an interactive graphic program for individual and population pharmacokinetic parameters estimation
13. In vitro release and in vivo serum fluoride levels and urinary excretion after different sodium fluoride tablets
14. Metabolism of fluorides
15. Effect of concurrent calcium ingestion on intestinal absorption of fluoride
16. Should we use fluoride to treat osteoporosis? A review
17. Etude de la biodisponibilité d'une préparation de comprimsés entérosolubles de fluorure de sodium
18. Osteoporosis: cause, treatment, prevention
19. Drugs, disease and gastric emptying
20. The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis
21. 3
22. The effects of sodium fluoride on calcium metabolism of subjects with metabolic bone diseases
23. Treatment of primary osteoporosis with fluoride and calcium. Clinical tolerance and fracture occurrence
24. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporsis. Comparison with conventional therapy
25. Biochemistry of fluoride in saliva
26. Does fluoridation of drinking-water prevent bone fragility and osteoporosis?
27. Effect of aluminum hydroxide on fluoride metabolism
28. Fluoride therapy in metabolic bone disease
29. Adverse effects of aluminum-containing antacids on mineral metabolism
30. Studies of fluoride and calcium metabolism in patients with osteoporosis
31. Studies on drug absorption and metabolism in elderly
32. Fluoride ion activity electrode as a suitable means for exact direct determination of urinary fluoride
33. Bioverfügbarkeit von fluorid aus verschiedenen salzen und unter dem Einfluss verschiedener Nahrungsbestandteile
34. Fluoride absorption: the influence of gastric acidity